141 related articles for article (PubMed ID: 23568104)
1. Tetrahydrohyperforin decreases cholinergic markers associated with amyloid-β plaques, 4-hydroxynonenal formation, and caspase-3 activation in AβPP/PS1 mice.
Carvajal FJ; Zolezzi JM; Tapia-Rojas C; Godoy JA; Inestrosa NC
J Alzheimers Dis; 2013; 36(1):99-118. PubMed ID: 23568104
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing.
Inestrosa NC; Tapia-Rojas C; Griffith TN; Carvajal FJ; Benito MJ; Rivera-Dictter A; Alvarez AR; Serrano FG; Hancke JL; Burgos PV; Parodi J; Varela-Nallar L
Transl Psychiatry; 2011 Jul; 1(7):e20. PubMed ID: 22832522
[TBL] [Abstract][Full Text] [Related]
3. Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.
Dinamarca MC; Cerpa W; Garrido J; Hancke JL; Inestrosa NC
Mol Psychiatry; 2006 Nov; 11(11):1032-48. PubMed ID: 16880827
[TBL] [Abstract][Full Text] [Related]
4. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
5. The hyperforin derivative IDN5706 occludes spatial memory impairments and neuropathological changes in a double transgenic Alzheimer's mouse model.
Cerpa W; Hancke JL; Morazzoni P; Bombardelli E; Riva A; Marin PP; Inestrosa NC
Curr Alzheimer Res; 2010 Mar; 7(2):126-33. PubMed ID: 19939230
[TBL] [Abstract][Full Text] [Related]
6. Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
Inestrosa NC; Godoy JA; Vargas JY; Arrazola MS; Rios JA; Carvajal FJ; Serrano FG; Farias GG
Neuromolecular Med; 2013 Sep; 15(3):549-69. PubMed ID: 23842742
[TBL] [Abstract][Full Text] [Related]
7. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
8. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrohyperforin induces mitochondrial dynamics and prevents mitochondrial Ca2+ overload after Aβ and Aβ-AChE complex challenge in rat hippocampal neurons.
Zolezzi JM; Carvajal FJ; Ríos JA; Ordenes D; Silva-Alvarez C; Godoy JA; Inestrosa NC
J Alzheimers Dis; 2013; 37(4):735-46. PubMed ID: 23948911
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
[TBL] [Abstract][Full Text] [Related]
11. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
12. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
[TBL] [Abstract][Full Text] [Related]
13. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
Dineley KT; Westerman M; Bui D; Bell K; Ashe KH; Sweatt JD
J Neurosci; 2001 Jun; 21(12):4125-33. PubMed ID: 11404397
[TBL] [Abstract][Full Text] [Related]
15. Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706.
Carvajal FJ; Inestrosa NC
Front Mol Neurosci; 2011; 4():19. PubMed ID: 21949501
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
17. Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice.
Aso E; Sánchez-Pla A; Vegas-Lozano E; Maldonado R; Ferrer I
J Alzheimers Dis; 2015; 43(3):977-91. PubMed ID: 25125475
[TBL] [Abstract][Full Text] [Related]
18. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
[TBL] [Abstract][Full Text] [Related]
19. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
Wiley JC; Pettan-Brewer C; Ladiges WC
Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
